Inari Medical

Biotech & Life Sciences · Aliso Viejo, United States · Founded 2011 · IPO 2020

Medical device company developing devices for the interventional treatment of cardiovascular diseases MoreLess

In 2011, Inari Medical was founded in Irvine, California, by Bob Rosenbluth, Brian Cox, and Paul Lubock. The company emerged from the medical device incubator Inceptus Medical, with a mission to innovate in the treatment of venous thromboembolism (VTE) and other vascular conditions.

Inari Medical developed mechanical thrombectomy devices designed to remove blood clots from veins, offering a minimally invasive alternative to traditional treatments. This innovation aimed to improve patient outcomes and reduce recovery times, addressing a significant need in the medical community.

The company gained momentum with a significant Series C funding round of $27 million, led by Gilde Healthcare, which enabled further development and commercialization of their products. This financial boost was crucial in expanding their market presence and accelerating product innovation.

Inari Medical's journey reached a pivotal moment in May 2020 when the company went public on the NASDAQ under the ticker symbol NARI. The IPO marked a significant milestone, reflecting the company's growth and its potential in the medical device industry.

Today, Inari Medical continues to focus on advancing its technologies and expanding its reach in the healthcare sector, driven by a commitment to improving patient care and outcomes through innovative solutions.

Valuation $2.5–5B

Revenue $500M–1B

EBITDA $15M

Headcount 500–1k

Total funding $10–50M

Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Talent graph

Inari Medical's talent

Book a demo to see the people

Employees mapped 642 incl. 3 AI specialists

Founders /100 quality score

Key operators 33 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Inari Medical's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Inceptus Medical

U.S. Venture Partners

Versant Ventures

Series B+ 1 investor entered at this stage

Gilde Healthcare

Global footprint

Where Inari Medical has talent and traffic

Workforce by country

24 countries with
team presence

🇺🇸 United States86.4%

🇩🇪 Germany3.5%

🇫🇷 France1.4%

🇦🇺 Australia1.1%

🇨🇷 Costa Rica0.9%

Top 5 of 24 shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States42.7%

🇨🇦 Canada18.2%

🇬🇧 United Kingdom11.8%

🇯🇵 Japan8.2%

🇮🇳 India7.3%

Top 5 markets shown

Patent intelligence

$81M patent portfolio · 66 active families

Estimated portfolio value

$81M

1.7% of market cap · 1.8× smaller than top peer Shockwave Medical ($145M)

66 active patent families

Where Inari Medical innovates Biomedical engineeringAir conditioningAspiration catheterBlood vesselCatheter

Where Inari Medical concentrates vs peers

Each axis is a top-10 topic across Inari Medical and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Inari Medical

An AI-synthesized read of the highest-engagement posts about Inari Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Inari Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles